Live Breaking News & Updates on Corbus pharmaceuticals company profile

Stay updated with breaking news from Corbus pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded to Outperform at Oppenheimer

Oppenheimer upgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Get Rating) from a market perform rating to an outperform rating in a research note published on Wednesday morning, The Fly reports. CRBP has been the subject of several other research reports. StockNews.com started coverage on shares of Corbus Pharmaceuticals in a report on Thursday, March 16th. […]

Institutional-trading-of-corbus-pharmaceuticals , News-ratings-for-corbus-pharmaceuticals-daily , Vident-investment-advisory , Corbus-pharmaceuticals-holdings-inc , Corbus-pharmaceuticals-company-profile , Corbus-pharmaceuticals , Virtu-financial , Corbus-pharmaceuticals-stock , Get-rating , Point-capital-management , Sigma-investments

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Down 17.7% in April

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 297,200 shares, a decrease of 17.7% from the March 31st total of 360,900 shares. Currently, 7.2% of the shares of the stock are short sold. Based […]

Renaissance-technologies , Nasdaq , Vident-investment-advisory , Corbus-pharmaceuticals-company-profile , Corbus-pharmaceuticals-price-performance , Corbus-pharmaceuticals , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-holdings-inc , Corbus-pharmaceuticals-holdings , Get-rating , Street-corp